“We are treating the inflammatory disease by crippling the cytokine storm.”
Invent Penn State
November 30, 2020
“We are treating the inflammatory disease by crippling the cytokine storm.”
Invent Penn State
November 30, 2020
Mind the Gaps: A Perspective from the World of Academic Spinouts
“Addressing technical gaps, gaps in funding, and gaps in expertise.”
Emerging BioTalk
November 11, 2020
“Funding Will Be Used to Advance the Company’s Novel Monoclonal Antibody.”
For Immediate Release
September 1, 2020
“The 2020 National Xconomy Awards Finalists”
The 2020 National Xconomy Awards are open to individuals, companies, and organizations working across the life sciences in the United States, and feature leaders in the biotech industry, medicine, academia, digital health, and healthcare.
The Advance Biotech Award, selected by MilliporeSigma, will present one winner with $250,000 in products and services that help emerging biotech companies face challenges and push the next generation of drugs to market. Two finalists will receive $10,000 each.
Xconomy, Inc.
Aug 12, 2020
“Semifinalist presentation for consideration to win the 2020 North America Advance Biotech Grant program.”
YouTube | MilliporeSigma Pharma and Biopharma Manufacturing Channel
August 4, 2020
An in-depth look at COVID-19’s pathogenesis: Through the eyes of Dr. Zissis Chroneos
“Through the eyes of Dr. Zissis Chroneos”
Hellenic News
April 16, 2020
Researchers learn how the immune system fights parasitic worms
“The findings could lead to better drugs to fight common infections.”
Penn State Health News
May 11, 2017